Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
TLPInvest™, founded by Dave Bunning, operates from Libertyville, Illinois, and has over 30 years of experience in global public markets. The firm serves as both Chief Executive Officer and Chief Investment Officer, overseeing a diverse investment strategy. TLPInvest manages a multi-asset class portfolio, focusing on various sectors and stages of investment.
TLPInvest invests across a wide range of stages, from Friends & Family to Series F and beyond, without limiting itself to a single sector. The firm takes a dynamic approach, influenced by macroeconomic trends, and engages in global public markets, real estate, venture capital, and private equity. This active investment strategy allows TLPInvest to capitalize on timely opportunities.
TLPInvest has a diversified philanthropic portfolio that includes partnerships with both early- and late-stage innovators. Notably, the firm has funded research leading to the first FDA-approved food allergy therapy, showcasing its commitment to impactful investments.
TLPInvest invests across a broad range of stages, including Friends & Family, Angel, Pre-seed, Seed, and up to Series F, as well as Growth Equity and Pre-IPO investments.
The firm does not limit itself to specific sectors but instead adopts a dynamic investment approach influenced by macroeconomic conditions, allowing for flexibility across various industries.
TLPInvest is characterized as an active investor, seeking the right opportunities at the right time, which enables them to adapt to changing market conditions.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.